NCT03649464 2022-10-07Investigation of Oral OKN-007 in Recurrent High-grade Glioma ParticipantsOblato, Inc.Phase 1/2 Withdrawn
NCT00226668 2008-01-03XERECEPT® (hCRF) for Primary Glioma Patients Requiring Dexamethasone to Treat Peritumoral Brain EdemaCeltic Pharma Development ServicesPhase 3 Withdrawn120 enrolled